1,722
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approach

ORCID Icon, , & ORCID Icon
Pages 302-312 | Received 04 Oct 2020, Accepted 08 Dec 2020, Published online: 06 Jan 2021

References

  • Álvarez B, Montero Á, Aramburu F, Calvo E, Ángel de la Casa M, Valero J, Hernando O, López M, Ciérvide R, García-Aranda M, et al. 2020. Radiotherapy for ostheoarticular degenerative disorders: when nothing else works. Osteoarthr Carti Open. 1(3–4):100016.
  • Ameri A, Rahnama N, Bozorgmehr R, Mokhtari M, Farahbakhsh M, Nabavi M, Shoaei SD, Izadi H, Kashi ASY, Dehbaneh HS. 2020. Low-dose whole-lung irradiation for COVID-19 pneumonia: short course results. Int J Radiat Oncol Biol Phys. 108(5):1134–1139.
  • Arenas M, Sabater S, Hernández V, Rovirosa A, Lara P, Biete A, Panes J. 2012. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 188(11):975–981.
  • Badakhshi H, Buadch V. 2014. Low dose radiotherapy for plantar fasciitis. Treatment outcome of 171 patients. Foot. 24(4):172–175.
  • Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, Kaina B. 2011. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci. 108(52):21105–21110.
  • Broerse JJ, Jansen JTM, Seegenschmiedt MH.2004. Carcinogenic risks in radiotherapy of benign diseases from head to heel. Radiothe Oncol. 71(1):1–2.
  • Calabrese E, Dhawan G, Kapoor R, Kozumbo W. 2019. Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose. Hum Exp Toxicol. 38(8):888–898.
  • Calabrese EJ, Calabrese V. 2013. Reduction of arthritic symptoms by low dose radiation therapy (LD-RT) is associated with an anti-inflammatory phenotype. Int J Radiat Biol. 89(4):278–286.
  • Calabrese EJ, Dhawan G. 2013. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 86(4):555–570.
  • Cameron MJ, Kelvin AA, Leon AJ, Cameron CM, Ran L, Xu L, Chu Y-K, Danesh A, Fang Y, Li Q, et al. 2012. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model. PLoS One. 7(9):e45842.
  • Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, et al. 2005. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ. 331(7508):77.
  • Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. 2016. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 19(2):181–193.
  • Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, Kritas S. 2020. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 34(2):1.
  • Deloch L, Fuchs J, Rückert M, Fietkau R, Frey B, Gaipl US. 2019. Low-dose irradiation differentially impacts macrophage phenotype in dependence of fibroblast-like synoviocytes and radiation dose. J Immunol Res. 2019:3161750.
  • Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giordano J, Calabrese EJ. 2020. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. 147:212–216.
  • Dubin I, Baylin G, Gobble JW. 1946. The effect of roentgen therapy on experimental virus pneumonia; on pneumonia produced in white mice by swine influenza virus. Am J Roentgenol Radium Ther. 55:478–481.
  • Fujiwara N, Kobayashi K. 2005. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 4(3):281–286.
  • Glatzel M, Frohlich D, Basecke S, Krauss A. 2004. Analgesic radiotherapy for osteoarthrosis of digital joints and rhizarthrosis. Radiother Oncol. 71:S24–S25.
  • Guilliams M, Lambrecht B, Hammad H. 2013. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol. 6(3):464–473.
  • Habraken Y, Piette J. 2006. NF-kappaB activation by double-strand breaks. Biochem Pharmacol. 72(9):1132–1141.
  • Hall E, Giaccia A. 2006. Radiobiology for the radiologist. Philadelphia: Lippincott Williams & Wilkins.
  • Heidenhain L, Fried C. 1924. Röntgenbestrahlung und Entzündung. Berlin: Springer.
  • Hess CB, Buchwald ZS, Stokes W, Switchenko JM, Nasti TH, Weinberg BD, Steinberg JP, Goddette KD, Ahmed R, Curran WJ. 2020. Low-dose whole-lung radiation for COVID-19 pneumonia: planned day-7 interim analysis of a registered clinical trial. medRxiv.
  • Hildebrandt G, Maggiorella L, Rödel F, Rödel V, Willis D, Trott K-R. 2002. Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro. Int J Radiat Biol. 78(4):315–325.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395(10223):497–506.
  • Jain V, Berman AT. 2018. Radiation pneumonitis: old problem, new tricks. Cancers. 10(7):222.
  • Jansen JTM, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM. 2005. Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol. 76(3):270–277.
  • Kaltenborn A, Carl UM, Hinsche T, Nitsche M, Hermann RM. 2017. Low-dose external beam radiotherapy for greater trochanteric pain syndrome: target volume definition and treatment outcome. Strahlenther Onkol. 193(4):260–268.
  • Kefayat A, Ghahremani F. 2020. Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword. Radiother Oncol. 147:224–225.
  • Keilholz L, Seegenschmiedt H, Sauer R. 1998. Radiotherapy for painful degenerative joint disorders. Indications, technique and clinical results. Strahlenther Onkol. 174(5):243–250.
  • Kern PM, Keilholz L, Forster C, Hallmann R, Herrmann M, Seegenschmiedt M-H. 2000. Low-dose radiotherapy selectively reduces adhesion of peripheral blood mononuclear cells to endothelium in vitro. Radiother Oncol. 54(3):273–282.
  • Kirkby C, Mackenzie M. 2020. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 147:221.
  • Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. 2020. Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiother Oncol. 147:217–220.
  • Kriz J, Seegenschmiedt HM, Bartels A, Micke O, Muecke R, Schaefer U, Haverkamp U, Eich HT. 2018. Updated strategies in the treatment of benign diseases – a patterns of care study of the german cooperative group on benign diseases. Adv Radiat Oncol. 3(3):240–244.
  • Lara PC, Burgos J, Macias D. 2020. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 23:27–29.
  • Large M. 2015. Cellular and molecular aspects of the anti-inflammatory effects of low-dose radiation therapy. Darmstadt: Technische Universität.
  • Large M, Hehlgans S, Reichert S, Gaipl US, Fournier C, Rödel C, Weiss C, Rödel F. 2015. Study of the anti-inflammatory effects of low-dose radiation: the contribution of biphasic regulation of the antioxidative system in endothelial cells. Strahlenther Onkol. 191(9):742–749.
  • Le RQ, Li L, Yuan W, Shord SS, Nie L, Habtemariam BA, Przepiorka D, Farrell AT, Pazdur R. 2018. FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell‐induced severe or life‐threatening cytokine release syndrome. Oncol. 23(8):943–947.
  • Little MP, Stovall M, Smith SA, Kleinerman RA. 2013. A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiation therapy for benign disease. Int J Radiat Oncol Biol Phys. 85(2):451–459.
  • Little MP, Zhang W, van Dusen R, Hamada N. 2020. Pneumonia after bacterial or viral infection preceded or followed by radiation exposure-a reanalysis of older radiobiological data and implications for low dose radiotherapy for COVID-19 pneumonia. Int J Radiat Oncol Biol Phys.DOI:10.1016/j.ijrobp.2020.09.052
  • Mahler EA, Minten MJ, Leseman-Hoogenboom MM, Poortmans PM, Leer JWH, Boks SS, van den Hoogen FH, den Broeder AA, van den Ende CH. 2019. Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial. Ann Rheum Dis. 78(1):83–90.
  • McIntire F, Smith JH. 1937. X-ray therapy in the treatment of pneumonia. Texas State J Med. 33:422–426.
  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Collaboration HAS. 2020. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 395(10229):1033–1034.
  • Merritt E, McPeak E. 1930. Roentgen irradiation in unresolved pneumonia. Am J Roentgenol. 23:45–48.
  • Micke O, Seegenschmiedt MH, Adamietz IA, Kundt G, Fakhrian K, Schaefer U, Muecke R. 2017. Low-dose radiation therapy for benign painful skeletal disorders: the typical treatment for the elderly patient? Int J Radiat Oncol Biol Phys. 98(4):958–963.
  • Milewska A, Chi Y, Szczepanski A, Barreto-Duran E, Liu K, Liu D, Guo X, Ge Y, Li J, Cui L. 2020. HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV. BioRxiv.
  • Monteleone G, Sarzi-Puttini PC, Ardizzone S. 2020. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2(5):e255–e256.
  • Montero A, Arenas M, Algara M. 2020. Low-dose radiation therapy: could it be a game-changer for COVID-19? Clin Translat Oncol. DOI:10.1007/s12094-020-02401-y
  • Musser JH, and Edsall D. 1905. A study of metabolism IX leukemia, uxder the influence of the x-ray. Trans Assoc Am Phys. 20:294.
  • Navarro G, Taroumian S, Barroso N, Duan L, Furst D. 2014. Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrums. Semin Arthritis Rheum. 43(4):458–469.
  • Niewald M, Fleckenstein J, Naumann S, Ruebe C. 2007. Long-term results of radiotherapy for periarthritis of the shoulder: a retrospective evaluation. Radiat Oncol. 2(1):34.
  • Ott O, Hertel S, Gaipl U, Frey B, Schmidt M, Fietkau R. 2012. Benign painful elbow syndrome. First results of a single center prospective randomized radiotherapy dose optimization trial. Strahlenther Onkol. 188(10):873–877.
  • Powell E. 1939. The treatment of acute pneumonias with roentgen rays. Am J Roentgenol Rad Ther. 41:404–414.
  • Prasanna PG, Woloschak GE, DiCarlo AL, Buchsbaum JC, Schaue D, Chakravarti A, Cucinotta FA, Formenti SC, Guha C, Hu DJ, et al. 2020. Low-Dose Radiation Therapy (LDRT) for COVID-19: benefits or risks? Radiat Res. 194(5):452–464.
  • Quimby AJ, Quimby WA. 1916. Unresolved pneumonia: successful treatment by Röngen Ray. AR Elliott.
  • Rödel F, Arenas M, Ott OJ, Fournier C, Georgakilas AG, Tapio S, Trott K-R, Gaipl US. 2020. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlenther Onkol. 196(8):679–674.
  • Rödel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US, Rödel C. 2012. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol. 2:120.
  • Rödel F, Hantschel M, Hildebrandt G, Schultze ‐Mosgau S, Rödel C, Herrmann M, Sauer R, Voll R. 2004. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int J Radiat Biol. 80(2):115–123.
  • Rödel F, Schaller U, Schultze-Mosgau S, Beuscher H-U, Keilholz L, Herrmann M, Voll R, Sauer R, Hildebrandt G. 2004. The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. Strahlenther Onkol. 180(4):194–200.
  • Roedel F, Kley N, Beuscher H, Hildebrandt G, Keilholz L, Kern P, Voll R, Herrmann M, Sauer R. 2002. Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol. 78(8):711–719.
  • Rothan HA, Byrareddy SN. 2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 109:102433.
  • Rousseau J, Johnson W, Harrell GT. 1942. The value of roentgen therapy in pneumonia which fails to respond to the sulfonamides. Radiology. 38(3):281–289.
  • Royo LT, Redondo GA, Pianetta MÁ, Prat MA. 2020. Low-dose radiation therapy for benign pathologies. Rep Pract Oncol Radiother.
  • Ruppert R, Seegenschmiedt M, Sauer R. 2004. Radiotherapie von Arthrosen. Der Orthopäde. 33(1):56–62.
  • Salomaa S, Cardis E, Bouffler SD, Atkinson MJ, Hamada N. 2020. Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence? Int J Radiat Biol. 96(10):1224–1224.
  • Schaue D, Marples B, Trott K. 2002. The effects of low-dose X-irradiation on the oxidative burst in stimulated macrophages. Int J Radiat Biol. 78(7):567–576.
  • Scott WR. 1939. X-ray therapy in the treatment of acute pneumonia: report covering the use of X-ray therapy in the treatment of pneumonia at the Niagara Falls Memorial Hospital, from Oct. 1, 1937, to Sept. 30, 1938. Radiology. 33(3):331–349.
  • Seegenschmiedt M, Micke O, Muecke R, Diseases G-M. 2015. Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol. 88(1051):20150080.
  • Seegenschmiedt MH, Keilholz L. 1998. Epicondylopathia humeri (EPH) and peritendinitis humeroscapularis (PHS): evaluation of radiation therapy long-term results and literature review. Radiother Oncol. 47(1):17–28.
  • Settle EB. 1941. The roentgen treatment of lobar pneumonia. Am J Roentgenol Rad Therapy. 45(4):591–599.
  • Shuryak I, Sachs RK, Brenner DJ. 2010. Cancer risks after radiation exposure in middle age. J Natl Cancer Inst. 102(21):1628–1636.
  • Speyer CL, Ward PA. 2011. Role of endothelial chemokines and their receptors during inflammation. J Invest Surg. 24(1):18–27.
  • Sun P, Qie S, Liu Z, Ren J, Xi JJ. 2020. Clinical characteristics of 50466 patients with 2019-nCoV infection. medRxiv.
  • Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD. 2020. Immunology of COVID-19: current state of the science. Immunity.
  • Valduvieco I, Biete A, Moreno LA, Gallart X, Rovirosa A, Saez J, Plana C, Peris P. 2017. Is anti-inflammatory radiotherapy an effective treatment in trochanteritis? Br J Radiol. 90(1069):20160520.
  • Wathelet MG, Orr M, Frieman MB, Baric RS. 2007. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol. 81(21):11620–11633.
  • Wunderlich R, Rühle PF, Deloch L, Rödel F, Fietkau R, Gaipl US, Frey B. 2019. Ionizing radiation reduces the capacity of activated macrophages to induce T-cell proliferation, but does not trigger dendritic cell-mediated non-targeted effects. Int J Radiat Biol. 95(1):33–43.
  • Yang P, Wang X. 2020. COVID-19: a new challenge for human beings. Cell Mol Immunol. 17(5):555–557.
  • Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X, Wei H. 2020. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev. 7(6):998–1002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.